PACB MonthlyMy game plan for 2025. Monthly wedge breakout, cup+handle formations on daily/weekly to resolve near +30 EOY
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−23.69 MXN
−6.46 B MXN
3.21 B MXN
262.18 M
About Pacific Biosciences of California, Inc.
Sector
Industry
CEO
Christian O. Henry
Website
Headquarters
Menlo Park
Founded
2000
FIGI
BBG01T8MJB30
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
Short Term Stock Watch - 07Dec2025 - $PACBTime for a breakout?
Nice potential short term swing trade.
Note: This is not a recommendation or investment advice, just a stock to watch. Do your own research before getting into a trade.
Pacific Biosciences of California, Inc. (NASDAQ: PACB) 1. Company Overview
About: Pacific Biosciences, also known as PacBio, is a life sciences technology firm specializing in sequencing solutions for complex genomic applications. Its core products include HiFi long-read sequencing and Single Molecule, Real-Time (SMRT) sequencing technologies. These pr
Pacb LongTarget the apex of the LOG chart pattern, been getting a lot of bullish block trade activity on my end.
PACB - +160% upside with a 1:3.5 RRSet-up nicely for a breakout.
Seems like its consolidating and due a move up higher on breakout.
I expect the move to be a 2x at least to $4-5.
BUT not yet broken out and I am waiting on confirmation of momentum.
Pacific Biosciences of California, Inc. - positive divergenceOn the 5 day chart price action has corrected 90% since closing the previous idea (below) on June 21st 2023 after a 200% rally. A number of reasons now exist to consider a new long position now that the short is closed.
1) RSI resistance breakout and backtest confirmation.
2) Strong regular bullis
PACB - Flushed Out - Potential 20 bagger hereOk so we are all looking for that next 20 bagger right? Biotechs and moreover disrupter Biotechs are so hated right now they are IMO a deal.
Now not all Biotechs will be big winners, some will go to zero, but if the potential to go to zero is there, it is best to buy near zero ;)......
So I am g
PACB - LONGAt the upcoming TD Cowen 44th Annual Health Care Conference and Barclays 26th Annual Global Healthcare Conference, PacBio is expected to present corporate updates, including recent achievements and product advancements, financial performance, and strategic outlook. The company may also discuss indus
PACB WeeklyHere's a little less optimistic outlook than the PACB Monthly chart. Spending more time near the lower trend line before moving higher towards upper trend line. Either way, all roads eventually lead to Rome.
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
PACB5630687
Pacific Biosciences of California, Inc. 1.375% 15-DEC-2030Yield to maturity
—
Maturity date
Dec 15, 2030
PACB5949325
Pacific Biosciences of California, Inc. 1.5% 15-AUG-2029Yield to maturity
—
Maturity date
Aug 15, 2029
See all PACB bonds
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange PACIFIC BIOSCIENCES CALIFORNIA INC stocks are traded under the ticker PACB.
PACB stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in PACIFIC BIOSCIENCES CALIFORNIA INC price.
We've gathered analysts' opinions on PACIFIC BIOSCIENCES CALIFORNIA INC future price: according to them, PACB price has a max estimate of 69.02 MXN and a min estimate of 19.72 MXN. Watch PACB chart and read a more detailed PACIFIC BIOSCIENCES CALIFORNIA INC stock forecast: see what analysts think of PACIFIC BIOSCIENCES CALIFORNIA INC and suggest that you do with its stocks.
PACB reached its all-time high on Apr 10, 2025 with the price of 25.22 MXN, and its all-time low was 25.22 MXN and was reached on Apr 10, 2025. View more price dynamics on PACB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PACB stock is 0.00% volatile and has beta coefficient of 0.49. Track PACIFIC BIOSCIENCES CALIFORNIA INC stock price on the chart and check out the list of the most volatile stocks — is PACIFIC BIOSCIENCES CALIFORNIA INC there?
Today PACIFIC BIOSCIENCES CALIFORNIA INC has the market capitalization of 6.84 B, it has increased by 23.78% over the last week.
Yes, you can track PACIFIC BIOSCIENCES CALIFORNIA INC financials in yearly and quarterly reports right on TradingView.
PACIFIC BIOSCIENCES CALIFORNIA INC is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
PACB earnings for the last quarter are 0.21 MXN per share, whereas the estimation was −3.97 MXN resulting in a 105.26% surprise. The estimated earnings for the next quarter are −3.94 MXN per share. See more details about PACIFIC BIOSCIENCES CALIFORNIA INC earnings.
PACIFIC BIOSCIENCES CALIFORNIA INC revenue for the last quarter amounts to 817.80 M MXN, despite the estimated figure of 836.04 M MXN. In the next quarter, revenue is expected to reach 726.07 M MXN.
PACB net income for the last quarter is 74.45 M MXN, while the quarter before that showed −1.20 B MXN of net income which accounts for 106.22% change. Track more PACIFIC BIOSCIENCES CALIFORNIA INC financial stats to get the full picture.
No, PACB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 24, 2025, the company has 575 employees. See our rating of the largest employees — is PACIFIC BIOSCIENCES CALIFORNIA INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PACIFIC BIOSCIENCES CALIFORNIA INC EBITDA is −4.42 B MXN, and current EBITDA margin is −137.72%. See more stats in PACIFIC BIOSCIENCES CALIFORNIA INC financial statements.
Like other stocks, PACB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PACIFIC BIOSCIENCES CALIFORNIA INC stock right from TradingView charts — choose your broker and connect to your account.